Bachem Holding AG Logo

Bachem Holding AG

A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.

BANB | SW

Overview

Corporate Details

ISIN(s):
CH1176493729 (+1 more)
LEI:
506700S81111XI7TG884
Country:
Switzerland
Address:
Hauptstrasse 144, 4416 Bubendorf

Description

Bachem is a technology company specializing in the development and manufacturing of peptides and oligonucleotides. As a contract development and manufacturing organization (CDMO), it provides a comprehensive range of products and services to the pharmaceutical and biotechnology industries. The company supports clients throughout the entire product lifecycle, from research and clinical development to commercial application. Its portfolio includes active pharmaceutical ingredients (APIs) as New Chemical Entities (NCEs) and generics, as well as an extensive catalog of research-grade products such as catalog peptides, amino acid derivatives, and custom synthesis services. Bachem also offers its expertise for cosmetic and diagnostic applications.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 01:00
Anne-Kathrin Stoller to become new CEO at Bachem
English 4.3 KB
2025-10-31 01:00
Anne-Kathrin Stoller wird neue CEO bei Bachem
German 4.8 KB
2025-10-23 02:00
Bachem announces progress in Building K start-up and expansion of its site in V…
English 3.6 KB
2025-10-23 02:00
Bachem gibt Fortschritte bei der Betriebsaufnahme von Gebäude K und die Erweite…
German 4.1 KB
2025-08-20 02:00
Bachem expands Corporate Executive Committee to include Chief Operations Office…
English 5.3 KB
2025-08-20 02:00
Bachem erweitert Konzernleitung um die Rolle des Chief Operations Officer
German 5.8 KB
2025-07-24 02:00
Bachem shows strong growth in the first half of 2025
English 10.8 KB
2025-07-24 02:00
Bachem mit starkem Wachstum im ersten Halbjahr 2025
German 12.1 KB
2025-06-03 02:00
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
English 4.7 KB
2025-06-03 02:00
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
German 7.7 KB
2025-02-27 01:00
Bachem increases sales and profitability
English 9.7 KB
2025-02-27 01:00
Bachem erhöht Umsatz und Profitabilität
German 11.3 KB
2024-07-25 02:00
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
English 7.9 KB
2024-07-25 02:00
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
German 8.5 KB
2024-05-28 02:00
Incident on construction site of Bachem in Bubendorf
English 2.9 KB

Automate Your Workflow. Get a real-time feed of all Bachem Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bachem Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bachem Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-06 N/A Non-Executive member Buy None 30,315.25 CHF

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.